tiprankstipranks
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
US Market

Lexeo Therapeutics, Inc. (LXEO) Income Statement

Compare
116 Followers

Lexeo Therapeutics, Inc. Income Statement

Last quarter (Q3 2024), Lexeo Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Lexeo Therapeutics, Inc.'s net income was $-29.49M. See Lexeo Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 654.00K$ 1.66M$ 518.48K
Gross Profit
$ -1.84M$ -491.00K$ 1.64M$ 518.48K
Operating Expenses
$ 66.67M$ 61.16M$ 52.29M$ 5.11M
Depreciation and Amortization
$ 1.84M$ 1.15M$ 13.40K$ 4.24K
EBITDA
$ -66.67M$ -58.04M$ -50.62M$ -4.58M
Operating Income
$ -68.51M$ -60.51M$ -50.64M$ -4.59M
Other Income/Expenses
$ 2.12M$ 1.23M$ 15.00K$ -565.00K
Pretax Income
$ -66.39M$ -59.28M$ -50.62M$ -5.15M
Net Income
$ -66.39M$ -59.28M$ -50.62M$ -5.15M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -2.49$ -2.40$ -2.05$ -0.21
Diluted EPS
$ -2.49$ -2.40$ -2.05$ -0.21
Weighted Average Shares Outstanding
26.65M 24.67M 24.67M 24.67M
Weighted Average Shares Outstanding (Diluted)
26.65M 24.67M 24.67M 24.67M
Currency in USD

Lexeo Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis